Back to search
FDAFDA · Food and drugs·Recall number D-1597-2014

Black Ant, 4600 mg, four capsules per box, , Manufacturer Timpo Bioengineering Co., Ltd, USA.,

Published September 24, 2014 · Recall initiated: March 28, 2014

Summary

FDA records drug Class I recall D-1597-2014, published September 24, 2014 and initiated March 28, 2014. Recalling firm: Nova Products, Inc.; Status: Terminated; Reported quantity: Unknown; Lot: 2006-3627878. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Black Ant because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nova Products, Inc.
Distributor
Nationwide to retailers and distributors
Lot
2006-3627878
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Black Ant, 4600 mg, four capsules per box, , Manufacturer Timpo Bioengineering Co., Ltd, USA., recalled?

Yes. FDA published recall D-1597-2014 on September 24, 2014. Reported hazard: Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Black Ant because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release